| 生物活性 | |||
|---|---|---|---|
| 靶点 |
|
||
| 描述 | (S)-Sunvozertinib ((S)-DZD9008), the S-enantiomer of Sunvozertinib), exhibits inhibitory activity against EGFR exon 20 NPH and ASV insertions, EGFR L858R/T790M mutation, and Her2 exon20 YVMA insertion (with IC50 values of 51.2 nM, 51.9 nM, 1 nM, and 21.2 nM, respectively). Additionally, (S)-Sunvozertinib inhibits BTK[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
1.71mL 0.34mL 0.17mL |
8.56mL 1.71mL 0.86mL |
17.12mL 3.42mL 1.71mL |
| 参考文献 |
|---|